DOZS.A.

Business and other management consultancy activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-11-23
Share capital
360 529 000,00 PLN
Registered address
Al.jerozolimskie 134, 02-305 Warszawa, Poland
Website
ww.dozsa.plWebsite inactive
Electronic delivery address
AE:PL-63808-39643-CWETB-19

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 123.51mMedianUSD 80.32kAverageUSD 1.95m
Net profit
This companyUSD 35.29mMedianUSD 3.14kAverageUSD 157.54k
Operating costs
This companyUSD 72.80mMedianUSD 57.96kAverageUSD 1.59m
Assets
This companyUSD 476.47mMedianUSD 66.89kAverageUSD 2.86m

Bank accounts

Registered as a VAT taxpayer on 2001-12-03. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

11 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
Nov 10, 2021Bankruptcy notice
Oct 25, 2021Commercial Companies Code notice
Feb 15, 2021Commercial Companies Code notice
Dec 18, 2020Commercial Companies Code notice
Dec 8, 2020Financial statement published

Public aid

No public aid cases recorded in the last 10 years.

Tenders

3 tenders recorded as contractor, with a total value of $290,991.

SubjectAmount
Bezgotówkowe wydawanie leków dla Klientów MOPR w 2026 r.
$111.3K
Bezgotówkowe wydawanie leków dla Klientów MOPR w 2025 roku
$86,816
Bezgotówkowe wydawanie leków dla klientów MOPR w Poznaniu w 2024 r.
$92,884

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Aleksandra Olszacka — Attorney-in-fact (joint)
Andrzej Smuga — Attorney-in-fact (joint)
Tibor Bartoszewicz — Vice President of the Management Board
Ewa Wasiak Zasada — Vice President of the Management Board

Manner of representation

The persons authorised to make declarations of will on behalf of the company are: 2 (two) members of the management board acting jointly, or 1 (one) member of the management board jointly with a commercial proxy. The commercial proxy makes declarations on behalf of the company jointly with a member of the management board.

Supervisory board

Alicja Koleśnik — Supervisory Board Member
Mariola Belina Prażmowska — Supervisory Board Member
Jacek Szwajcowski — Supervisory Board Member

Ownership

Owner
Corporation Of European Pharmaceutical Distributors N.v.

Beneficial owners

Person
Zbigniew Jacek Molenda (63)
Jacek Romuald Szwajcowski (62)

Subsidiaries

NameStake
100%
100%
Apteki Cefarmsp. z o.o.
99.9957%

Competitors

Name
Respect Energy HoldingS.A.
BisarS.A.
Servier Polskasp. z o.o.
Spencer Stuart Polandsp. z o.o.
Nexia Advicerosp. z o.o.
Fundusz Hipoteczny DomS.A.
Prestige Inwestycjesp. z o.o.
HRUPsp. z o.o.
Kancelaria Czerniakowskasp. z o.o.
Plemet Internationalsp. z o.o.

Change history

DateEvent
2017-01-18Share capital change
2014-11-06Address change
2011-04-20Share capital change
2009-07-06Share capital change
2009-01-07Address change

FAQ

Last updated: 2026-09-30